AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10. 9 billion in cash, according to a Financial Times report.

Source: [MarketWatch](https://www.marketwatch.com/story/abbvie-would-gain-an-experimental-eczema-drug-by-buying-biotech-report-caf24728?mod=mw_rss_topstories)

Sponsored